KBC Group NV

SEC CIK: 0001411133
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 179,508
Value: $111.9M
% of portfolio: 0.2%
Quarters held: 22; Since Q1 2021

Holdings of REGN by KBC Group NV, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	179,508	$111.9M	0.2%	+141,035+366.6%	Added	Holders
Q1 2026	38,473	$29.7M	0.1%	+258+0.7%	Added	Holders
Q4 2025	38,215	$29.5M	0.1%	+4,953+14.9%	Added	Holders
Q3 2025	33,262	$18.7M	<0.1%	−3,310−9.1%	Reduced	Holders
Q2 2025	36,572	$19.2M	0.1%	−112,868−75.5%	Reduced	Holders
Q1 2025	149,440	$94.8M	0.3%	+12,793+9.4%	Added	Holders
Q4 2024	136,647	$97.3M	0.3%	+102,198+296.7%	Added	Holders
Q3 2024	34,449	$36.2M	0.1%	+70.0%	Added	Holders
Q2 2024	34,442	$36.2M	0.1%	+188+0.5%	Added	Holders
Q1 2024	34,254	$33.0M	0.1%	−31,273−47.7%	Reduced	Holders
Q4 2023	65,527	$57.6M	0.2%	−1,058−1.6%	Reduced	Holders
Q3 2023	66,585	$54.8M	0.2%	−4,730−6.6%	Reduced	Holders
Q2 2023	71,315	$51.2M	0.2%	−4,531−6.0%	Reduced	Holders
Q1 2023	75,846	$62.3M	0.3%	−33,233−30.5%	Reduced	Holders
Q4 2022	109,079	$78.7M	0.4%	+46,999+75.7%	Added	Holders
Q3 2022	62,080	$42.8M	0.2%	−21,455−25.7%	Reduced	Holders
Q2 2022	83,535	$49.4M	0.2%	−3,217−3.7%	Reduced	Holders
Q1 2022	86,752	$60.6M	0.2%	−145,494−62.6%	Reduced	Holders
Q4 2021	232,246	$146.7M	0.5%	+87,909+60.9%	Added	Holders
Q3 2021	144,337	$87.3M	0.3%	+12,496+9.5%	Added	Holders
Q2 2021	131,841	$73.6M	0.3%	−15,873−10.7%	Reduced	Holders
Q1 2021	147,714	$69.9M	0.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.